Fatty acid oxidation & ketone bodies - PowerPoint PPT Presentation

About This Presentation
Title:

Fatty acid oxidation & ketone bodies

Description:

Biochemistry – PowerPoint PPT presentation

Number of Views:265
Slides: 31
Provided by: m.prasadnaidu
Tags: good

less

Transcript and Presenter's Notes

Title: Fatty acid oxidation & ketone bodies


1
Fatty Acid Oxidation and Ketone Bodies
  • M.Prasad Naidu
  • MSc Medical Biochemistry,
  • Ph.D.Research Scholar

2
OXIDATION OF FATTY ACIDS KETOGENESIS
  • The initial event in the utilization of fat as an
    energy source is the hydrolysis of
    triacylglycerol by lipases

3
  • Epinephrine, norepinephrine, glucagon, and
    adrenocorticotropic hormone stimulate the
    adenylate cyclase of adipose cells, and thus
    cause lipolysis.

4
Fatty acids are synthesized and degraded by
different mechanisms
  • Fatty acids are both oxidized to acetyl-CoA and
    synthesized from acetyl-CoA. Although the
    staring material of one process is identical to
    the product of the other, fatty acid oxidation is
    not the simple reverse of fatty acid
    biosynthesis. It is an entirely different
    process taking place in separate compartment of
    the cell. This allows each process to be
    individually controlled.

5
Fatty acids are synthesized and degraded by
different mechanisms Synthesis
Oxidation
  • Cytosol
  • Intermediates are covalently linked to ACP
  • Fatty acid synthase contain multienzyme
    activities
  • Utilizes NADP as coenzyme
  • Requires both ATP and bicarbonate ion
  • Mitochondrial matrix
  • Bonded to CoA
  • Degradative enzymes are not associated
  • Utilizes NAD and FAD as coenzymes
  • Generates ATP
  • Aerobic process

6
Step 1 Activation of fatty acids to acyl-CoA
Acyl-CoA synthetases are found in the endoplasmic
reticulum, peroxisomes, and inside and on the
outer membrane of mitochondria. Several acyl-CoA
synthetases have been described, each for fatty
acids of different chain length.
Acyl CoA AMP 2Pi 2H
R-COO- CoA ATP H20
7
Step 2 Long-chain fatty acids penetrate inner
mitochondrial membrane as carnitine derivatives.
Carnitine (ß-hydroxy-g-trimethylammonium
butyrate) is widely distributed and abundant in
muscle. Carnitine palmitoyltransferase-I,
present in the outer mitochondrial membrane,
catalyzes the following reaction
8
(No Transcript)
9
Step 3 ß-oxidation of fatty acids involves
successive cleavage with release of acetyl-CoA.
Fatty acid oxidase are found in the mitochondrial
matrix or inner membrane adjacent to the
respiratory chain in the inner membrane.
10
Oxidation of unsaturated fatty acids occurs by a
modified b-oxidation pathway
11
 Oxidation of fatty acids produces a large
quantity of ATP Palmitoyl CoA 7 FAD 7 NAD
7 CoA 7H2O  8 acetyl CoA 7
FADH2 7 NADH 7 H Oxidation of NADH -
3ATP '' FADH2 - 2 ATP
'' Acetyl-CoA - 12 ATP 7 FADH2 yields 147
NADH yields 218 acetyl-CoA yields 96 Total 131
ATP 2 high energy phosphate bonds are consumed
in the activation of palmitate Net yield is 129
ATP or 129 X 51.6 6656 kJ
12
TRIACYLGLYCEROLS ARE HIGHLY CONCENTRATED ENERGY
STORES
The initial event in the utilization of fat as an
energy source is the hydrolysis of
triacylglycerol by lipases.
13
 -Reduced and anhydrous Complete oxidation of
fatty acids yields 9 kCal/g, where as, proteins
and carbohydrates yield 4 kCal/g. A 70 kg
man 100,000 kCal in triacylglycerols 25,00
0 kCal in proteins (muscles) 600 kCal in
glycogen 400 kCal in glucose -Triacylglycer
ols constitute about 11 kg of his total body
weight. If this amount were stored in glycogen,
his total body weight would be 55 kg greater.-In
mammals, the major site of accummulation of
triacylglycerols is the cytoplasm of adipose
cells (fat cells). Droplets of triacylglycerol
coalesce to form a large globule, which may
occupy most of the cell volume. -Adipose cells
are specialized for the synthesis and storage of
triacylglycerols and for their mobilization into
fuel molecules that are transported to other
tissues by the blood.
14
Peroxisomes oxidize very long chain fatty acids
  • Very long chain acyl-CoA synthetase facilitates
    the oxidation of very long chain fatty acids
    (e.g., C20, C22). These enzymes are induced by
    high-fat diets and by hypolipidemic drugs such as
    Clofibrate. ß-oxidation takes place and ends at
    octanoyl-CoA. It is subsequently removed from
    the peroxisomes in the form of octanoyl and
    acetylcarnitine, and both are further oxidized in
    mitochondria.

15
a- and w-oxidation of fatty acids are specialized
pathways
  •  a-oxidation i.e., removal of one carbon at a
    time from the carboxyl end of the molecule has
    been detected in brain tissue. It does not
    generate CoA intermediates and does not generate
    high-energy phosphates.
  •  w-oxidation is a minor pathway and is brought
    about by cytochrome P450 in the endoplasmic
    reticulum. CH3 group is converted to a -CH2OH
    group that subsequently is oxidized to -COOH,
    thus forming a dicarboxylic acid. They
    subsequently undergo ß-oxidation and are excreted
    in the urine.

16
(No Transcript)
17
KETOGENESIS
  • It occurs when there is a high rate of fatty acid
    oxidation in the liver
  • These three substances are collectively known as
    the ketone bodies (also called acetone bodies or
    acetone). Enzymes responsible for ketone bodies
    formation are associated with mitochondria.

18
(No Transcript)
19
(No Transcript)
20
(No Transcript)
21
KETOGENESIS IS REGULATED AT THREE CRUCIAL STEPS
  • 1. Adipose tissue Factors regulating
    mobilization of free fatty acids from adipose
    tissue are important in controlling ketogenesis
  • 2. Liver After acylation, fatty acids undergo
    ß-oxidation or esterified to triacylglycerol or
    ketone bodies.
  • a. CPT-1 regulates entry of long-chain acyl
    groups into mitochondria prior to ß-oxidation.
    Its activity is low in the fed state, and high in
    starvation.

22
  • Fed state Malonyl-CoA formed in the fed state
    is a potent inhibitor of CPT-1. Under these
    conditions, free fatty acids enter the liver cell
    in low concentrations and are nearly all
    esterified to acylglycerols and transported out
    as VLDL.
  • Starvation Free fatty acid concentration
    increases with starvation, acetyl-CoA carboxylase
    is inhibited and malonyl-CoA decreases releasing
    the inhibition of CPT-I and allowing more
    ß-oxidation.
  • These events are reinforced in starvation by
    decrease in insulin/glucagon ratio. This causes
    inhibition of acetyl-CoA carboxylase in the liver
    by phosphorylation.

23
  • In short, ß-oxidation from free fatty acids is
    controlled by the CPT-I gateway into the
    mitochondria, and the balance of free fatty acid
    uptake not oxidized is esterified.
  • 3. Acetyl-CoA formed from ß-oxidation of fatty
    acids is either oxidized in TCA cycle or it forms
    ketone bodies.

24
(No Transcript)
25
(No Transcript)
26
CLINICAL ASPECTS
  • 1. Carnitine-deficiency can occur in newborn
    or preterm infants owing to inadequate
    biosynthesis or renal leakage. Losses can also
    occur in hemodialysis.
  • Symptoms hypoglycemia due to reduced
    gluconeogenesis resulting from impaired fatty
    acid oxidation, resulting in muscle weakness
    (Reye's syndrome).
  •  
  • Carnitine is supplemented with diet.
  •  
  •  

27
CLINICAL ASPECTS (cont)
  • 2. Deficiency of Carnitine palmitoyltransferase-I
    and -II
  •  
  • I Deficiency affects only liver, resulting in
    reduced fatty acid oxidation and ketogenesis with
    hypoglycemia.
  • II Deficiency skeletal muscle
  • Sulfonylureas (glyburide and tolbutamide) inhibit
    CPT and reduce fatty acid oxidation

28
CLINICAL ASPECTS (cont)
  • 3. Inherited defects in the ß-oxidation lead to
    nonketotic hypoglycemia, coma, and fatty liver.
    Defects in long-chain 3-hydroxyacyl-CoA
    dehydrogenase, short-chain 3-hydroxyacyl-CoA
    dehydrogenase and 3-ketoacyl-CoA thiolase,
    HMG-CoA lyase are known.
  • 4. Jamaican vomiting sickness It is caused by
    eating unripe fruit of the akee tree which
    contains a toxin, hypoglycin, that inactivates
    medium-and short-chain acyl-CoA dehydrogenase,
    inhibiting ß-oxidation resulting in hypoglycemia
    with excretion of medium- and short-chain mono-
    and dicarboxylic acids.

29
CLINICAL ASPECTS (cont)
  • 5. Dicarboxylic aciduria It is characterized
    by excretion of C6-C10 w-dicarboxylic acids and
    by nonketotic hypoglycemia due to deficiency of
    medium-chain acyl-CoA dehydrogenase. This
    impairs ß-oxidation but increases w-oxidation
    which are then shortened by ß-oxidation to
    medium-chain dicarboxylic acids, which are
    excreted.
  • 6. Refsum's disease A rare neurologic disorder
    caused by accumulation of phytanic acid, formed
    from phytol, a constituent of chlorophyll.
    Phytanic acid contains a methyl group on carbon 3
    that blocks ß-oxidation. Normally, an initial
    a-oxidation removes the methyl group, but
    person's with this disease have an inherited
    deficiency in a-oxidation.

30
CLINICAL ASPECTS (cont)
  • 7. Zellweger's (cerebrohepatorenal) syndrome
    Due to rare inherited absence of peroxisomes in
    all tissues. They accumulate C26-C38 polynoic
    acids in brain tissue owing to inability to
    oxidize long-chain fatty acids in peroxisomes.
  • Ketoacidosis results from prolonged ketosis
  •  
  • Ketonemia- higher than normal quantities of
    ketone bodies in blood 
  • Ketonuria- higher than normal quantities of
    ketone bodies in urine. 
  • Ketosis the overall condition is called ketosis.
Write a Comment
User Comments (0)
About PowerShow.com